This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

Dear Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties : As we prepare to end 2025, we would like to provide you with this open letter summarizing our ...

The following guide offers a detailed overview of several classes of medications that research links to a higher risk of ...

The RespireRx Group holds exclusive licenses and owns patents and patent applications or rights thereto for certain families of chemical compounds that claim the chemical structures and their uses in ...

The group of researchers were the first to take snapshots of the moment naloxone reverses an opioid overdose in the brain.

A class of synthetic drugs called nitazines have been around since the 1950s — but are quickly gaining a foothold in street drugs.

Scientists have visualized for the first time how opioids such as loperamide and the antidote naloxone engage a key brain receptor, offering insight that could lead to better pain treatments.

Scientists have known for decades that opioids relieve pain by binding to molecular switches in the brain called mu-opioid receptors. What they didn't know—until now—was exactly what happens next. A ...

This study presents important information about the role of mu opioid receptors in neurotransmission between the medial habenula and the interpeduncular nucleus. The authors provide convincing ...

It’s dangerous. It’s toxic. And it may provide hope for millions in agony. Pain management is among the most commonly reportedly reasons for medical cannabis use, but side effects have stymied many ...